Clinical

Dataset Information

0

Mixed reality application MS Teams using in 3 scenarios


ABSTRACT: Interventions: Group 1: The Remote Assist application allows discussion or collaboration in teams with a shared view of a patient-specific case. A post-market follow-up (PMCF) observation will confirm the safety as well as an acceptable benefit/risk ratio of the tool in different scenarios. Instead of the telephone or other means of communication, remote assist via VSI HoloMedicine of the MS Team tool will be used in three different scenarios. The following scenarios are evaluated: Adding to the operating room (Whipple) (n=3), indication discussion with collegium (n=3), and emergency department support (ileus, cholelithiasis, appendicitis). The purpose of this qualitative study is to evaluate the teams use of VSI HoloMedicine, in the context of surgery, physician on-call, and the emergency department for the following purposes. Evaluate: Confirm the performance of the teams integration of VSI HoloMedicine (remote assist / 3D hologram / streaming / voice quality). Deployment in different scenarios (OR / emergency / on-call) in terms of remote collaboration. Evaluation of usability, advantages and disadvantages Confirmation of the safety of the medical device Satisfaction of the users Observation of any unforeseen risks related to the function, Ensuring continued acceptance of the risk-benefit ratio. Measurement of mental workload (NASA-TLX). Primary outcome(s): The Remote Assist application enables discussion or collaboration in teams with a shared view of a patient-specific case. A post-market follow-up (PMCF) observation will confirm the safety as well as an acceptable benefit/risk ratio of the tool in different scenarios. Instead of the telephone or other means of communication, remote assist via VSI HoloMedicine of the MS Team tool will be used in three different scenarios. The following scenarios are evaluated: Adding to the operating room (Whipple) (n=3), indication discussion with colleagues (n=3), and emergency support (ileus, cholelithiasis, appendicitis). The aim is long-term post-marketing clinical follow-up (PMCF) of the performance, clinical utility, and safety of the product with respect to MS Teams use of VSI HoloMedicine. Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: other

DISEASE(S): Paralytic Ileus And Intestinal Obstruction Without Hernia,Malignant Neoplasm Of Pancreas,Acute Appendicitis,Cholelithiasis

PROVIDER: 93683 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2016-09-27 | PXD002952 | Pride
| 2389176 | ecrin-mdr-crc
2021-11-03 | PXD024101 | Pride
2016-11-25 | GSE59686 | GEO
2017-04-27 | MSV000081024 | MassIVE
2018-04-20 | PXD008092 | Pride
2005-04-21 | GSE2458 | GEO
2010-06-10 | E-GEOD-2458 | biostudies-arrayexpress
2021-01-07 | E-MTAB-9978 | biostudies-arrayexpress
2015-07-17 | PXD002131 | Pride